Publications

Supplementary content for the 2022/23 Annual Report, outlining ACPCC’s publications for the financial year.

Assessing Canadian women’s preferences for cervical cancer screening: A brief report.

Authors: Zhu P Tatar O Haward B Griffin-Mathieu G

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study. 

Authors: Zammit, C.M Creagh, N.S McDermott, T Smith, M.A

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.

Authors: Thompson EF Hoang L Höhn AK Palicelli A

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Supporting gynaecological pathology: volunteering at home and abroad.

Authors: Talia KL van der Griend R

Pathology. Volume 55. Supplement 1, S3, February 2023

Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.

Authors: Talia KL Ratnayake G McCluggage WG

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

The diverse morphology and immunophenotype of ovarian endometrioid carcinomas.

Authors: Talia KL McCluggage WG

Pathology. 2023 Apr;55(3):269-286. doi: 10.1016/j.pathol.2023.01.003. Epub 2023 Jan 21. PMID: 36759286.

Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated with Endometriosis and Ovarian Epithelial Neoplasia.

Authors: Talia KL McCluggage WG

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873

The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.

Authors: Talia KL Banet N Buza N

Pathology. 2023 Feb;55(1):8-18. doi: 10.1016/j.pathol.2022.11.004. Epub 2022 Nov 23. PMID: 36503635.

The spread of coronavirus disease 2019 (COVID-19) via staff work and household networks in residential aged-care services in Victoria, Australia, May–October 2020.

Authors: Sullivan, S. Sadewo, G. Brotherton, J. Kaufman, C.

Infect Control Hosp Epidemiol . 2023 Aug;44(8):1334-1341. doi: 10.1017/ice.2022.243. Epub 2022 Oct 20.

Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Authors: Park KJ Selinger CI Alvarado-Cabrero I Duggan MA

Int J Gynecol Pathol. 2022 Nov 1;41(Suppl 1):S64-S89. doi: 10.1097/PGP.0000000000000909. Epub 2022 Aug 19. PMID: 36305535.

Human papillomavirus vaccine effectiveness by number of doses. updated systematic review of data from national immunization programs.

Vaccine 2022 Sep 2;40(37):5413-5432. doi: 10.1016/j.vaccine.2022.06.065. Epub 2022 Aug 12.

Public health implications and opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.

Authors: Kreimer AR Cernuschi T Rees H Brotherton JML

JNCI: Journal of the National Cancer Institute, Volume 115, Issue 3, March 2023, Pages 246–249

Management of Chlamydia Cases in Australia (MoCCA): protocol for a non-randomised implementation and feasibility trial.

Authors: Jane L Goller Jacqueline Coombe Meredith Temple-Smith Helen Bittleston

BMJ Open 2022;12:e067488. doi:10.1136/ bmjopen-2022-067488

IARC Handbooks of Cancer Prevention Volume 18

IARC Handb Cancer Prev. 18:1–456

Annual immunisation coverage report 2020.

Authors: Hull B Hendry A Dey A Brotherton J

Commun Dis Intell 2022;46 Epub

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Authors: Garland SM Iftner T Cuschieri K Kaufmann AM

J Clin Virol . 2023 Feb:159:105349. doi: 10.1016/j.jcv.2022.105349. Epub 2022 Dec 8.

Under-screened Aboriginal and Torres Strait Islander women’s perspectives on cervical screening.

Authors: Butler TL Lee N Anderson K Brotherton JML

PLOS ONE

Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India

Authors: Anu Mary Oommen Partha Basu Anne George Cherian Eric Zomawia

Implementation Science Communications (2023) 4:62

Our Publications

The C4 Centre for Research Excellence has coordinated research and evaluation activities in cervical cancer control, which has enabled the C4 to significantly contribute to the national and global evidence-base and peer reviewed literature in all aspects of cervical cancer control since its formation in 2017.

2022

2021

2020

2019

2018

2017

Publications

The ACPCC’s research team (in collaboration with our key partners) continues to undertake research and evaluation of public health activities supporting cervical cancer elimination in Australia and internationally, with outcomes published in peer-reviewed journals and health-care focussed articles.

Search publications:

Assessing Canadian women’s preferences for cervical cancer screening: A brief report.

Authors: Zhu P Tatar O Haward B Griffin-Mathieu G

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study. 

Authors: Zammit, C.M Creagh, N.S McDermott, T Smith, M.A

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.

Authors: Thompson EF Hoang L Höhn AK Palicelli A

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Supporting gynaecological pathology: volunteering at home and abroad.

Authors: Talia KL van der Griend R

Pathology. Volume 55. Supplement 1, S3, February 2023

Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.

Authors: Talia KL Ratnayake G McCluggage WG

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

The diverse morphology and immunophenotype of ovarian endometrioid carcinomas.

Authors: Talia KL McCluggage WG

Pathology. 2023 Apr;55(3):269-286. doi: 10.1016/j.pathol.2023.01.003. Epub 2023 Jan 21. PMID: 36759286.

Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated with Endometriosis and Ovarian Epithelial Neoplasia.

Authors: Talia KL McCluggage WG

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873

The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.

Authors: Talia KL Banet N Buza N

Pathology. 2023 Feb;55(1):8-18. doi: 10.1016/j.pathol.2022.11.004. Epub 2022 Nov 23. PMID: 36503635.

The spread of coronavirus disease 2019 (COVID-19) via staff work and household networks in residential aged-care services in Victoria, Australia, May–October 2020.

Authors: Sullivan, S. Sadewo, G. Brotherton, J. Kaufman, C.

Infect Control Hosp Epidemiol . 2023 Aug;44(8):1334-1341. doi: 10.1017/ice.2022.243. Epub 2022 Oct 20.

Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Authors: Park KJ Selinger CI Alvarado-Cabrero I Duggan MA

Int J Gynecol Pathol. 2022 Nov 1;41(Suppl 1):S64-S89. doi: 10.1097/PGP.0000000000000909. Epub 2022 Aug 19. PMID: 36305535.

Human papillomavirus vaccine effectiveness by number of doses. updated systematic review of data from national immunization programs.

Vaccine 2022 Sep 2;40(37):5413-5432. doi: 10.1016/j.vaccine.2022.06.065. Epub 2022 Aug 12.

Public health implications and opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.

Authors: Kreimer AR Cernuschi T Rees H Brotherton JML

JNCI: Journal of the National Cancer Institute, Volume 115, Issue 3, March 2023, Pages 246–249

Management of Chlamydia Cases in Australia (MoCCA): protocol for a non-randomised implementation and feasibility trial.

Authors: Jane L Goller Jacqueline Coombe Meredith Temple-Smith Helen Bittleston

BMJ Open 2022;12:e067488. doi:10.1136/ bmjopen-2022-067488

IARC Handbooks of Cancer Prevention Volume 18

IARC Handb Cancer Prev. 18:1–456

Annual immunisation coverage report 2020.

Authors: Hull B Hendry A Dey A Brotherton J

Commun Dis Intell 2022;46 Epub

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Authors: Garland SM Iftner T Cuschieri K Kaufmann AM

J Clin Virol . 2023 Feb:159:105349. doi: 10.1016/j.jcv.2022.105349. Epub 2022 Dec 8.

Under-screened Aboriginal and Torres Strait Islander women’s perspectives on cervical screening.

Authors: Butler TL Lee N Anderson K Brotherton JML

PLOS ONE

A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial

Authors: Lawton B. MacDonald EJ Storey F , Stanton JA

JMIR Res Protoc . 2023 Sep 14:12:e51643. doi: 10.2196/51643.

Publications & Reports

News & Media Coverage

Events

Our Partners

READ UP ON IT

Growing number of patients DIY-ing cervical screening to detect HPV

Victoria is leading the way in cancer screening surveillance and reporting

ACPCC launches the Inaugural Victorian Cancer Screening Annual Statistical Report. The Australian Centre for the Prevention of Cervical Cancer is pleased to announce the launch of the Inaugural Victorian Annual Cancer Screening Statistical Report….

Victorians Urged To Keep Up With Cancer Screening Checks

Monday, 26 February 2024. The Allan Labor Government is calling on Victorians to make sure their cancer screenings checks are up to date in a major push to boost screening rates for breast, bowel…

Major Australian Government funding boost to eliminate cervical cancer in our region

Australia is stepping up its regional leadership in the elimination of cervical cancer, with the announcement today of a $12.5 million Australian Government grant to a consortium of leading Australian and international nongovernment health organisations….

Australia takes ‘EPICC’ step towards fairer cervical cancer outcomes in region

Australia is stepping up its global leadership in the elimination of cervical cancer, with the announcement today of a $12.5 million Australian Government regional aid grant to a nongovernment consortium headed by the Daffodil Centre, a joint…

National Strategy for the Elimination of Cervical Cancer in Australia and our region

The C4 is thrilled about the announcement today by the Australian Government of the release of the National Strategy for the Elimination of Cervical Cancer and a $48.2 million investment to support implementation of…

Congratulations to all those involved in a successful virtual Eliminating Cervical Cancer 2023 (ECC2023) Conference!

On Friday 17th November, Cervical Cancer Elimination Day of Action 2023, the C4 hosted the first ECC2023 (previously named the Preventing Cervical Cancer Conference [PCC]). The theme of the conference was ‘From Prevention to…

Going for Gold: new strategy and funding set to make preventable cervical cancer a disease of the past

This cervical cancer awareness week, the Australian Government has launched a landmark strategy set to make preventable cervical cancer a disease of the past, setting Australia on the path to becoming the first country…

An EPICC affair: Australian leadership in cervical cancer recognised with a major Australian Government grant

Australia is stepping up its regional leadership in the elimination of cervical cancer, with the announcement today of a $12.5 million Australian Government grant to a consortium of leading Australian and international nongovernment health…

Media Release: Eliminating Cervical Cancer in Australia and our Region

The Albanese Labor Government is leading the way for Australia to become the first country in the world to eliminate cervical cancer, with the release of the National Strategy for the Elimination of Cervical…

Assistant Minister Kearney – Elimination Strategy Launch Speech

I’m delighted to be here today for such an historic event in Australian medical history. Before I begin, I’d like to acknowledge we’re meeting today on the lands of the Wurundjeri Woi-wurrung people of…

ECC2023: Friday, 17th November

Make an Individual Donation

Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr inte
llegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.

READ UP ON IT

Get in touch

To find out more about what we do or how we can work together, please get in touch.

Publications

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Pathology. Volume 55. Supplement 1, S3, February 2023

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

Pathology. 2023 Apr;55(3):269-286. doi: 10.1016/j.pathol.2023.01.003. Epub 2023 Jan 21. PMID: 36759286.

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873

Pathology. 2023 Feb;55(1):8-18. doi: 10.1016/j.pathol.2022.11.004. Epub 2022 Nov 23. PMID: 36503635.

Infect Control Hosp Epidemiol . 2023 Aug;44(8):1334-1341. doi: 10.1017/ice.2022.243. Epub 2022 Oct 20.

Int J Gynecol Pathol. 2022 Nov 1;41(Suppl 1):S64-S89. doi: 10.1097/PGP.0000000000000909. Epub 2022 Aug 19. PMID: 36305535.

Vaccine 2022 Sep 2;40(37):5413-5432. doi: 10.1016/j.vaccine.2022.06.065. Epub 2022 Aug 12.

JNCI: Journal of the National Cancer Institute, Volume 115, Issue 3, March 2023, Pages 246–249

BMJ Open 2022;12:e067488. doi:10.1136/ bmjopen-2022-067488

IARC Handb Cancer Prev. 18:1–456

Commun Dis Intell 2022;46 Epub

J Clin Virol . 2023 Feb:159:105349. doi: 10.1016/j.jcv.2022.105349. Epub 2022 Dec 8.

PLOS ONE

Implementation Science Communications (2023) 4:62

Our Publications

2022

2021

2020

2019

2018

2017

Publications

Search publications:

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Pathology. Volume 55. Supplement 1, S3, February 2023

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

Pathology. 2023 Apr;55(3):269-286. doi: 10.1016/j.pathol.2023.01.003. Epub 2023 Jan 21. PMID: 36759286.

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873

Pathology. 2023 Feb;55(1):8-18. doi: 10.1016/j.pathol.2022.11.004. Epub 2022 Nov 23. PMID: 36503635.

Infect Control Hosp Epidemiol . 2023 Aug;44(8):1334-1341. doi: 10.1017/ice.2022.243. Epub 2022 Oct 20.

Int J Gynecol Pathol. 2022 Nov 1;41(Suppl 1):S64-S89. doi: 10.1097/PGP.0000000000000909. Epub 2022 Aug 19. PMID: 36305535.

Vaccine 2022 Sep 2;40(37):5413-5432. doi: 10.1016/j.vaccine.2022.06.065. Epub 2022 Aug 12.

JNCI: Journal of the National Cancer Institute, Volume 115, Issue 3, March 2023, Pages 246–249

BMJ Open 2022;12:e067488. doi:10.1136/ bmjopen-2022-067488

IARC Handb Cancer Prev. 18:1–456

Commun Dis Intell 2022;46 Epub

J Clin Virol . 2023 Feb:159:105349. doi: 10.1016/j.jcv.2022.105349. Epub 2022 Dec 8.

PLOS ONE

JMIR Res Protoc . 2023 Sep 14:12:e51643. doi: 10.2196/51643.

Publications & Reports

News & Media Coverage

Events

Our Partners

READ UP ON IT

Related News Article

DONATIONS

Make an Individual Donation

READ UP ON IT

Success Stories

Get in touch

Download "How to take your own HPV test"

Available in your language.

Int. J. Environ. Res. Public Health 2022, 19, 15776.

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873

Int. J. Environ. Res. Public Health 2022, 19, 15776.

International Journal of Gynecological Pathology 42(1): p 70-77, January 2023. | DOI: 10.1097/PGP.0000000000000873